Biocon Biologics
Monalisa Nayak is an experienced professional in the biotechnology field, currently serving as an Executive at Biocon Biologics since January 2024. Prior to this role, Monalisa held an internship at the same company from March 2023 to September 2023, focusing on biosimilar production upstream. Additionally, Monalisa gained experience as a Trainee at Imgenex India Pvt. Ltd from February 2022 to August 2022. Educationally, Monalisa earned a Master of Science in Biotechnology from Siksha 'O' Anusandhan University in July 2022 and completed a Bachelor's degree in Biotechnology at Trident Academy of Creative Technology in September 2020.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics